European S1 guideline for the treatment of hidradenitis suppurativa/acne inversa
Article Properties
-
LanguageEnglish
-
DOI (url)
-
Publication Date2015/01/30
-
Indian UGC (journal)
-
Refrences196
-
Citations686
-
C.C. Zouboulis Departments of Dermatology, Venereology, Allergology and Immunology Dessau Medical Center Dessau Germany
-
N. Desai St Johns Institute of Dermatology Guys & St Thomas' NHS Trust London UK
-
L. Emtestam Section of Dermatology I Department of Medicine Karolinska Institutet Huddinge University Hospital Stockholm Sweden
-
R.E. Hunger Department of Dermatology University of Bern Bern Switzerland
-
D. Ioannides Department of Dermatology Aristotle University of Thessaloniki Thessaloniki Greece
-
I. Juhász Department of Dermatology University of Debrecen Debrecen Hungary
-
J. Lapins Section of Dermatology I Department of Medicine Karolinska Institutet Huddinge University Hospital Stockholm Sweden
-
L. Matusiak Department of Dermatology, Venereology and Allergology Wroclaw Medical University Wroclaw Poland
-
E.P. Prens Department of Dermatology Erasmus MC University Medical Center Rotterdam The Netherlands
-
J. Revuz Department of Dermatology Henri Mondor Hospital Creteil France
-
S. Schneider‐Burrus Department of Dermatology, Venerology and Allergology University Hospital Charité Berlin Germany
-
J.C. Szepietowski Department of Dermatology, Venereology and Allergology Wroclaw Medical University Wroclaw Poland
-
H.H. van der Zee Department of Dermatology Erasmus MC University Medical Center Rotterdam The Netherlands
-
G.B.E. Jemec Department of Dermatology Roskilde Hospital University of Copenhagen Copenhagen Denmark
Abstract
Cite
Zouboulis, C.C., et al. “European S1 Guideline for the Treatment of Hidradenitis Suppurativa Acne Inversa”. Journal of the European Academy of Dermatology and Venereology, vol. 29, no. 4, 2015, pp. 619-44, https://doi.org/10.1111/jdv.12966.
Zouboulis, C., Desai, N., Emtestam, L., Hunger, R., Ioannides, D., Juhász, I., Lapins, J., Matusiak, L., Prens, E., Revuz, J., Schneider‐Burrus, S., Szepietowski, J., van der Zee, H., & Jemec, G. (2015). European S1 guideline for the treatment of hidradenitis suppurativa/acne inversa. Journal of the European Academy of Dermatology and Venereology, 29(4), 619-644. https://doi.org/10.1111/jdv.12966
Zouboulis, C.C., N. Desai, L. Emtestam, R.E. Hunger, D. Ioannides, I. Juhász, J. Lapins, et al. “European S1 Guideline for the Treatment of Hidradenitis Suppurativa Acne Inversa”. Journal of the European Academy of Dermatology and Venereology 29, no. 4 (2015): 619-44. https://doi.org/10.1111/jdv.12966.
Zouboulis C, Desai N, Emtestam L, Hunger R, Ioannides D, Juhász I, et al. European S1 guideline for the treatment of hidradenitis suppurativa/acne inversa. Journal of the European Academy of Dermatology and Venereology. 2015;29(4):619-44.
Journal Categories
Medicine
Dermatology
Medicine
Medicine (General)
You May Also Like
- Severe Psoriasis – Oral Therapy with a New Retinoid
- Severity Scoring of Atopic Dermatitis: The SCORAD Index
- Clinical Validation and Guidelines for the SCORAD Index: Consensus Report of the European Task Force on Atopic Dermatitis
- A comprehensive review and evaluation of the side effects of the tumor necrosis factor alpha blockers etanercept, infliximab and adalimumab
- Induction and exacerbation of psoriasis with TNF-blockade therapy: A review and analysis of 127 cases
Refrences
| Title | Journal | Journal Categories | Citations | Publication Date |
|---|---|---|---|---|
| Efficacy of adalimumab in recalcitrant hidradenitis suppurativa | European Journal of Dermatology |
| 16 | 2009 |
| Hidradenitis Suppurativa | Dermatologic Surgery |
| 15 | 2008 |
| Hldradenitis suppurativa—lack of success with 13-cis-retinoic acid | British Journal of Dermatology |
| 7 | 1982 |
| Hidradenitis Suppurativa | JAMA |
| 17 | 1972 |
| Hidradenitis Suppurativa | JAMA |
| 26 | 1968 |
Citations
Citations Analysis
The category
Medicine: Medicine (General) 470
is the most commonly referenced area in studies that cite this article. The first research to cite this article was titled An Update on Medical Treatment Options for Hidradenitis Suppurativa and was published in 2015. The most recent citation comes from a 2024 study titled Real‐world adalimumab survival and discontinuation factors in hidradenitis suppurativa. This article reached its peak citation in 2019, with 103 citations. It has been cited in 211 different journals, 26% of which are open access. Among related journals, the British Journal of Dermatology cited this research the most, with 54 citations. The chart below illustrates the annual citation trends for this article.